This program project has two interrelated long term goals to understand: (1) how trisomy 21 leads to Down Syndrome; and (2) in as much detail as possible the organization and evolution of the DNA of chromosome 21. Progress will be highly synergistic and best optimized by the united multifaceted approach. This endeavor should have great significance for understanding how the human genome is organized and functions during human development and for delineating approaches to gene mapping which could be applied to the entire human genome. Two projects (Patterson, Kao) focus mainly on somatic cell genetics and molecular biology to create a detailed physical map of chromosome 21. Techniques include preparation of somatic cells hybrids containing only portions of chromosome 21, microdissection and microcloning of regions of chromosome 21, and regional mapping of DNA sequences using standard pulsed-field gel electrophoreses. The chromosome 21 translocation breakpoints in these hybrids will serve as molecular landmarks for a physical map of chromosome 21. Dr. Gardiner will create a library of large (>IOOkb) DNA fragments of chromosome 21 in an early manipulatable form in a yeast host and use this library to isolate and analyze specific regions of chromosome 21, allowing direct study of any area of chromosome 21. Drs. Jones and Drabkin will study gene regulation on chromosome 21 which has to do with immune response and leukemia using somatic cell genetic and molecular approaches. They will take interspecific human/Chinese hamster cell hybrids containing chromosome 21 translocation chromosomes as a part of their work, which will be used for mapping. Dr. Drabkin's work will focus on translocations associated with leukemia and mechanisms by which extra copies of genes on chromosome 21 may lead to leukemia. Dr. Jones project will focus on induction of the interferon response and similar immunogenetic studies of other cell surface molecules, i.e. beta amyloid. Dr Law will isolate gene sequences on chromosome 21 and study the possible role of repeated sequences in gene regulation. She will use molecular cloning, DNA sequencing and in situ hybridization. Genes of interest and blocks of genes on chromosome 21 regions will be introduced into cells in culture and ultimately into experimental animals to understand how these genes might, when present in 3 copies instead of the normal two, lead to certain aspects of Down Syndrome.
| Régnier, Vinciane; Billard, Jean-Marie; Gupta, Sapna et al. (2012) Brain phenotype of transgenic mice overexpressing cystathionine ?-synthase. PLoS One 7:e29056 |
| Moat, Stuart; Carling, Rachel; Nix, Authur et al. (2010) Multicentre age-related reference intervals for cerebrospinal fluid serine concentrations: implications for the diagnosis and follow-up of serine biosynthesis disorders. Mol Genet Metab 101:149-52 |
| Nielsen, Darci M; Evans, Jeffrey J; Derber, William J et al. (2009) Mouse model of fragile X syndrome: behavioral and hormonal response to stressors. Behav Neurosci 123:677-86 |
| Knox, Aaron J; Graham, Christine; Bleskan, John et al. (2009) Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis. Gene 429:23-30 |
| Hoger, Joachim; Patterson, David; Hoger, Harald et al. (2009) Mice transgenic for reduced folate carrier: an animal model of Down syndrome? Amino Acids 36:349-57 |
| Patterson, David; Graham, Christine; Cherian, Christina et al. (2008) A humanized mouse model for the reduced folate carrier. Mol Genet Metab 93:95-103 |
| Pennington, Bruce F (2006) From single to multiple deficit models of developmental disorders. Cognition 101:385-413 |
| Yao, Guimei; Chen, Xiao-Ning; Flores-Sarnat, Laura et al. (2006) Deletion of chromosome 21 disturbs human brain morphogenesis. Genet Med 8:1-7 |
| Wenger, Galen R; Schmidt, Cecilia; Davisson, Muriel T (2004) Operant conditioning in the Ts65Dn mouse: learning. Behav Genet 34:105-19 |
| Gardiner, Katheleen; Davisson, Muriel T; Crnic, Linda S (2004) Building protein interaction maps for Down's syndrome. Brief Funct Genomic Proteomic 3:142-56 |
Showing the most recent 10 out of 155 publications
